NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and QuantuMDx today announced a collaboration to develop point-of-care diagnostic tests specifically for the Asian population.

Under the terms of the deal, QuantuMDx's Singapore-based subsidiary QMDx Asia and GIS will develop the tests using QuantuMDx's Q-POC handheld point-of-care device. The Newcastle, UK-based firm will commercialize the tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.